Today new member who is highly connected to science and venture capital Mr.Chris Mizer of Vivarius Capital Inc. has been appointed in the science Advisory Board of TSOI. Take a look at the members profile ..very impressive track record of having connections with reputed Fortune 500 pharma companies. It appears Chris is a great fit and timed to perfection as Tim is ready to market Nanostilbene, QM, Neuroleukin straightaway from TSOI lab. There by ensuring gradual month-to-month sales picking up by catering to all the cancer stage 4 patients and giving them an opportunity to explore the chance to live. We should look forward for sales and marketing push of TSOIs products viz. NS and QM to begin and expand to include Nano Cannabidiol and Neuroleukin gradually.
BTW, Chris Mizer is already into funding new United Cancer Centers all over USA for critical patients in stage 4 and provide them treatment with NS.